Single-center study utilizing C(2) level as monitoring tool in de novo renal transplant recipients treated with Neoral.
Keshavamurthy
M
M
Department of Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Al Ahmadi
I
I
Mohammed Raza
S
S
Baynton
R
R
Al Meshari
K
K
Al Shaibani
K
K
D000328:Adult; D019540:Area Under Curve; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000379:methods; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012044:Regression Analysis; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine; D011241:Prednisone; D016559:Tacrolimus